MosChip Technologies Employee Stock Options

MosChip Technologies Acquisition Worth ₹266.7 Cr

MosChip will acquire Vayavya Labs for Rs.266.71 Crore in cash and shares. Completion awaits RBI and exchange approvals and shareholder approval of a preferential issue.

Value

₹266.7 Cr

Execution

Within 15 days of the later of receipt of all requisite approvals or shareholder approval of the preferential issue to VLPL sellers

MosChip Technologies Results Update

MosChip's Q2 FY27 press release showed revenue of ₹119.08 Crore and an EBITDA loss of ₹18.82 Crore. Cost escalations on a turnkey ASIC project drove weaker profit.

MosChip Technologies Fund Raise of ₹112.2 Cr

MosChip Technologies approved a preferential issue of 50,50,686 equity shares at Rs.222 to 69 investors, raising about Rs.112.19 Crore. The board approval covers the fund raise, with an AGM/postal ballot dated 25 November 2026.

Value

₹112.2 Cr

MosChip Technologies Q2 FY27 Results: Net Loss of ₹30.4 Cr

MosChip Technologies Ltd reported revenue from operations of ₹119.1 Cr (-18.9% YoY) and a net loss of ₹30.4 Cr for Q2 FY27.

Key figure

Net loss ₹30.4 Cr

MosChip Technologies Board Meeting Date

MosChip's board meets 28 October 2026 to consider quarterly results, the Vayavya Labs acquisition and a preferential issue. Trading window closes from 1 October.

MosChip Technologies Share Pledge

Mayuka Holdings pledged 2.58 crore Moschip shares (13.21% stake) to Infina Finance on October 12, 2026. This increases promoter encumbrance exposure.

Aye Finance Employee Stock Options

Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.

Aarti Pharmalabs Employee Stock Options

Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.

OnEMI Technology Solutions Employee Stock Options

OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.

Bliss GVS Pharma Employee Stock Options

Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.

Bandhan Bank Employee Stock Options

Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.

Maxvolt Energy Industries Employee Stock Options

Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.

Execution

Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date